Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
A high expression of fibroblast activation protein (FAP) was observed in multiple sarcomas, indicating an enormous potential for PET/CT using 68Ga-radiolabeled inhibitors of FAP (FAPI). Therefore, this retrospective study aimed to evaluate the role of the novel hybrid imaging probe for sarcomas as a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21 May 2021
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2021, Volume: 48, Issue: 12, Pages: 3918-3924 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-021-05374-4 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-021-05374-4 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00259-021-05374-4 |
| Author Notes: | Stefan A. Koerber, R. Finck, K. Dendl, M. Uhl, T. Lindner, C. Kratochwil, M. Röhrich, H. Rathke, G. Ungerechts, S. Adeberg, K. Herfarth, D. Jaeger, J. Debus, U. Haberkorn, F.L. Giesel |
| Summary: | A high expression of fibroblast activation protein (FAP) was observed in multiple sarcomas, indicating an enormous potential for PET/CT using 68Ga-radiolabeled inhibitors of FAP (FAPI). Therefore, this retrospective study aimed to evaluate the role of the novel hybrid imaging probe for sarcomas as a first clinical evaluation. |
|---|---|
| Item Description: | Gesehen am 29.03.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-021-05374-4 |